SG Americas Securities’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
SG Americas Securities's ELV Position: Q2 2026 in Review
SG Americas Securities increased its Elevance Health (ELV) stake by 72% in Q2 2026, buying an estimated $213M and bringing the position to 1,372,089 shares worth $531M. The position accounts for 0.3% of the portfolio, ranked #52.
SG Americas Securities first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- SG Americas Securities held 1,372,089 shares of Elevance Health worth $531M as of Q2 2026.
- SG Americas Securities bought 575,536 Elevance Health shares in Q2 2026, an estimated $213M.
- Elevance Health made up 0.3% of SG Americas Securities's portfolio in Q2 2026, its #52 holding.
- SG Americas Securities first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
- 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.